Evidence map›Paper›PMID 36172348›Full record

ArticleFrontiers in immunology2022

Manipulation of tissue factor-mediated basal PAR-2 signalling on macrophages determines sensitivity for IFNγ responsiveness and significantly modifies the phenotype of murine DTH.

Hannah Wilkinson, Hugh Leonard, Michael G Robson, Richard Smith, ElLi Tam, John H McVey, Daniel Kirckhofer, Daxin Chen, Anthony Dorling

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Hannah WilkinsonDepartment of Inflammation Biology, School of Immunology & Microbial Sciences, King's College London, Guy's Hospital, London, United Kingdom.
Hugh LeonardDepartment of Inflammation Biology, School of Immunology & Microbial Sciences, King's College London, Guy's Hospital, London, United Kingdom.
Michael G RobsonDepartment of Inflammation Biology, School of Immunology & Microbial Sciences, King's College London, Guy's Hospital, London, United Kingdom.
Richard SmithDepartment of Inflammation Biology, School of Immunology & Microbial Sciences, King's College London, Guy's Hospital, London, United Kingdom.
ElLi TamDepartment of Inflammation Biology, School of Immunology & Microbial Sciences, King's College London, Guy's Hospital, London, United Kingdom.
John H McVeySchool of Bioscience & Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, United Kingdom.
Daniel KirckhoferDepartment of Early Discovery Biochemistry, Genentech Inc., South San Francisco, CA, United States.
Daxin ChenDepartment of Inflammation Biology, School of Immunology & Microbial Sciences, King's College London, Guy's Hospital, London, United Kingdom.
Anthony DorlingDepartment of Inflammation Biology, School of Immunology & Microbial Sciences, King's College London, Guy's Hospital, London, United Kingdom.
King's College London · GBGuy's Hospital · GBUniversity of Surrey · GB

Funding

Medical Research Council G0401591Medical Research Council MC_PC_15031Medical Research Council MC_PC_18052Medical Research Council MR/J006742/1
6 · The paper itself

Abstract

Background: Tissue factor (TF) generates proteases that can signal through PAR-1 and PAR-2. We have previously demonstrated PAR-1 signalling primes innate myeloid cells to be exquisitely sensitive to interferon-gamma (IFNγ). In this work we explored how TF mediated PAR-2 signalling modulated responsiveness to IFNγ and investigated the interplay between PAR-1/-2 signalling on macrophages. Methodology: We characterised how TF through PAR-2 influenced IFNγ sensitivity Results: TF delivered a basal signal through PAR-2 that upregulated SOCS3 expression and blunted M1 polarisation after IFNγ stimulation, opposing the priming achieved by signalling through PAR-1. PAR-1 and -2 agonists or antagonists could be used in combination to modify this basal signal Conclusions: TF-mediated signalling through PARs-1 and -2 act in a homeostatic way to determine how myeloid cells respond to IFNγ. 3-MP, an agent that simultaneously inhibits PAR-1 whilst delivering a PAR-2 signal, can almost completely abolish immune responses dependent on M1 polarisation, particularly if potency is enhanced by targeting to cell membranes; this has potential therapeutic potential in multiple diseases.

Indexed as

Interferon-gammaThromboplastinAnimalsMacrophagesMiceOxazolonePeptide HydrolasesPhenotypeReceptor, PAR-1Interferon-gammaOxazolonePeptide HydrolasesReceptor, PAR-1Thromboplastininnate immunitymacrophageprotease (proteinase)-activated receptorthrombintype IV hypersensitivity

Identifiers

PMID36172348
PMCPMC9510775
OpenAlexW4297872518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.